190 related articles for article (PubMed ID: 25798940)
1. Potent anti-proliferative, pro-apoptotic activity of the Maytenus royleanus extract against prostate cancer cells: evidence in in-vitro and in-vivo models.
Shabbir M; Syed DN; Lall RK; Khan MR; Mukhtar H
PLoS One; 2015; 10(3):e0119859. PubMed ID: 25798940
[TBL] [Abstract][Full Text] [Related]
2. Tissue microarray profiling and integrative proteomics indicate the modulatory potential of Maytenus royleanus in inhibition of overexpressed TPD52 in prostate cancers.
Shabbir M; Mukhtar H; Syed D; Razak S; Afsar T; Almajwal A; Badshah Y; Aldisi D
Sci Rep; 2021 Jun; 11(1):11935. PubMed ID: 34099820
[TBL] [Abstract][Full Text] [Related]
3. Oleanolic acid inhibits cell survival and proliferation of prostate cancer cells in vitro and in vivo through the PI3K/Akt pathway.
Li X; Song Y; Zhang P; Zhu H; Chen L; Xiao Y; Xing Y
Tumour Biol; 2016 Jun; 37(6):7599-613. PubMed ID: 26687646
[TBL] [Abstract][Full Text] [Related]
4. Phytochemical analysis and Evaluation of hepatoprotective effect of Maytenus royleanus leaves extract against anti-tuberculosis drug induced liver injury in mice.
Shabbir M; Afsar T; Razak S; Almajwal A; Khan MR
Lipids Health Dis; 2020 Mar; 19(1):46. PubMed ID: 32178678
[TBL] [Abstract][Full Text] [Related]
5. Cytotoxic effects of N-(3-chloro-1,4-dioxo 1,4-dihydro-naphthalen-2-yl)-benzamide on androgen-dependent and -independent prostate cancer cell lines.
Kanaan YM; White DF; Das JR; Berhe S; Bakare O; Kenguele H; Beyene D; Zhou Y; Day AA; Copeland RL
Anticancer Res; 2010 Feb; 30(2):519-27. PubMed ID: 20332464
[TBL] [Abstract][Full Text] [Related]
6. Galbanic acid decreases androgen receptor abundance and signaling and induces G1 arrest in prostate cancer cells.
Zhang Y; Kim KH; Zhang W; Guo Y; Kim SH; Lü J
Int J Cancer; 2012 Jan; 130(1):200-12. PubMed ID: 21328348
[TBL] [Abstract][Full Text] [Related]
7.
Afolabi SO; Olorundare OE; Babatunde A; Albrecht RM; Koketsu M; Syed DN; Mukhtar H
Oxid Med Cell Longev; 2019; 2019():6726312. PubMed ID: 31827691
[TBL] [Abstract][Full Text] [Related]
8. Apoptotic effect of tolfenamic acid in androgen receptor-independent prostate cancer cell and xenograft tumor through specificity protein 1.
Choi ES; Shim JH; Jung JY; Kim HJ; Choi KH; Shin JA; Nam JS; Cho NP; Cho SD
Cancer Sci; 2011 Apr; 102(4):742-8. PubMed ID: 21241418
[TBL] [Abstract][Full Text] [Related]
9. Growth Arrest-Specific 6 (GAS6) Promotes Prostate Cancer Survival by G
Lee E; Decker AM; Cackowski FC; Kana LA; Yumoto K; Jung Y; Wang J; Buttitta L; Morgan TM; Taichman RS
J Cell Biochem; 2016 Dec; 117(12):2815-2824. PubMed ID: 27153245
[TBL] [Abstract][Full Text] [Related]
10. Ericifolin: a novel antitumor compound from allspice that silences androgen receptor in prostate cancer.
Shamaladevi N; Lyn DA; Shaaban KA; Zhang L; Villate S; Rohr J; Lokeshwar BL
Carcinogenesis; 2013 Aug; 34(8):1822-32. PubMed ID: 23568956
[TBL] [Abstract][Full Text] [Related]
11. Tumor apoptosis induced by epoxide-containing piperazines, a new class of anti-cancer agents.
Eilon GF; Gu J; Slater LM; Hara K; Jacobs JW
Cancer Chemother Pharmacol; 2000; 45(3):183-91. PubMed ID: 10663635
[TBL] [Abstract][Full Text] [Related]
12. A novel dietary triterpene Lupeol induces fas-mediated apoptotic death of androgen-sensitive prostate cancer cells and inhibits tumor growth in a xenograft model.
Saleem M; Kweon MH; Yun JM; Adhami VM; Khan N; Syed DN; Mukhtar H
Cancer Res; 2005 Dec; 65(23):11203-13. PubMed ID: 16322271
[TBL] [Abstract][Full Text] [Related]
13. CDK inhibitors induce mitochondria-mediated apoptosis through the activation of polyamine catabolic pathway in LNCaP, DU145 and PC3 prostate cancer cells.
Arisan ED; Obakan P; Coker-Gurkan A; Calcabrini A; Agostinelli E; Unsal NP
Curr Pharm Des; 2014; 20(2):180-8. PubMed ID: 23701543
[TBL] [Abstract][Full Text] [Related]
14. Targeting prostate cancer with HTI-286, a synthetic analog of the marine sponge product hemiasterlin.
Hadaschik BA; Ettinger S; Sowery RD; Zoubeidi A; Andersen RJ; Roberge M; Gleave ME
Int J Cancer; 2008 May; 122(10):2368-76. PubMed ID: 18240145
[TBL] [Abstract][Full Text] [Related]
15. Potent activity of the Hsp90 inhibitor ganetespib in prostate cancer cells irrespective of androgen receptor status or variant receptor expression.
He S; Zhang C; Shafi AA; Sequeira M; Acquaviva J; Friedland JC; Sang J; Smith DL; Weigel NL; Wada Y; Proia DA
Int J Oncol; 2013 Jan; 42(1):35-43. PubMed ID: 23152004
[TBL] [Abstract][Full Text] [Related]
16. Assessment of phytochemicals, antioxidant, anti-lipid peroxidation and anti-hemolytic activity of extract and various fractions of Maytenus royleanus leaves.
Shabbir M; Khan MR; Saeed N
BMC Complement Altern Med; 2013 Jun; 13():143. PubMed ID: 23800043
[TBL] [Abstract][Full Text] [Related]
17. Prazosin displays anticancer activity against human prostate cancers: targeting DNA and cell cycle.
Lin SC; Chueh SC; Hsiao CJ; Li TK; Chen TH; Liao CH; Lyu PC; Guh JH
Neoplasia; 2007 Oct; 9(10):830-9. PubMed ID: 17971903
[TBL] [Abstract][Full Text] [Related]
18. 20(S)-25-methoxyl-dammarane-3beta, 12beta, 20-triol, a novel natural product for prostate cancer therapy: activity in vitro and in vivo and mechanisms of action.
Wang W; Wang H; Rayburn ER; Zhao Y; Hill DL; Zhang R
Br J Cancer; 2008 Feb; 98(4):792-802. PubMed ID: 18253123
[TBL] [Abstract][Full Text] [Related]
19. Survivin gene silencing sensitizes prostate cancer cells to selenium growth inhibition.
Liu X; Gao R; Dong Y; Gao L; Zhao Y; Zhao L; Zhao X; Zhang H
BMC Cancer; 2010 Aug; 10():418. PubMed ID: 20698994
[TBL] [Abstract][Full Text] [Related]
20. Small molecule tolfenamic acid inhibits PC-3 cell proliferation and invasion in vitro, and tumor growth in orthotopic mouse model for prostate cancer.
Sankpal UT; Abdelrahim M; Connelly SF; Lee CM; Madero-Visbal R; Colon J; Smith J; Safe S; Maliakal P; Basha R
Prostate; 2012 Nov; 72(15):1648-58. PubMed ID: 22473873
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
